IL39167A - X-ray shading agents containing a water soluble salt of 3-acetamido-5-hydroxy-acetamido-2,4,6-triiodobenzoic acid - Google Patents

X-ray shading agents containing a water soluble salt of 3-acetamido-5-hydroxy-acetamido-2,4,6-triiodobenzoic acid

Info

Publication number
IL39167A
IL39167A IL39167A IL3916772A IL39167A IL 39167 A IL39167 A IL 39167A IL 39167 A IL39167 A IL 39167A IL 3916772 A IL3916772 A IL 3916772A IL 39167 A IL39167 A IL 39167A
Authority
IL
Israel
Prior art keywords
salt
agent
ray shading
water
base
Prior art date
Application number
IL39167A
Other languages
English (en)
Other versions
IL39167A0 (en
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of IL39167A0 publication Critical patent/IL39167A0/xx
Publication of IL39167A publication Critical patent/IL39167A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL39167A 1971-04-10 1972-04-10 X-ray shading agents containing a water soluble salt of 3-acetamido-5-hydroxy-acetamido-2,4,6-triiodobenzoic acid IL39167A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2118219A DE2118219C3 (de) 1971-04-10 1971-04-10 Neues Röntgenkontrastmittel

Publications (2)

Publication Number Publication Date
IL39167A0 IL39167A0 (en) 1972-06-28
IL39167A true IL39167A (en) 1976-01-30

Family

ID=5804754

Family Applications (1)

Application Number Title Priority Date Filing Date
IL39167A IL39167A (en) 1971-04-10 1972-04-10 X-ray shading agents containing a water soluble salt of 3-acetamido-5-hydroxy-acetamido-2,4,6-triiodobenzoic acid

Country Status (15)

Country Link
AT (2) AT318801B (xx)
AU (1) AU463194B2 (xx)
BE (1) BE781889A (xx)
CA (1) CA987339A (xx)
CH (1) CH574740A5 (xx)
DD (1) DD95265A5 (xx)
DE (1) DE2118219C3 (xx)
ES (1) ES401603A1 (xx)
FR (1) FR2132810B1 (xx)
GB (1) GB1391843A (xx)
HU (1) HU163446B (xx)
IL (1) IL39167A (xx)
IT (1) IT1048929B (xx)
NL (1) NL7204789A (xx)
ZA (1) ZA722396B (xx)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH641682A5 (en) * 1978-10-05 1984-03-15 Daeniker Felix X-ray contrast medium

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3076024A (en) * 1954-02-19 1963-01-29 Sterling Drug Inc Acylated 3, 5-diaminopolyhalobenzoic acids
DE1129260B (de) * 1961-05-12 1962-05-10 Schering Ag Roentgenkontrastmittel

Also Published As

Publication number Publication date
DD95265A5 (xx) 1973-01-20
HU163446B (xx) 1973-08-28
AU463194B2 (en) 1975-07-02
BE781889A (fr) 1972-10-10
GB1391843A (en) 1975-04-23
IT1048929B (it) 1980-12-20
AT316523B (de) 1974-07-10
DE2118219A1 (de) 1972-10-26
CH574740A5 (xx) 1976-04-30
FR2132810B1 (xx) 1975-03-14
CA987339A (en) 1976-04-13
AT318801B (de) 1974-11-25
AU4063372A (en) 1973-10-04
DE2118219B2 (de) 1980-07-03
FR2132810A1 (xx) 1972-11-24
DE2118219C3 (de) 1981-07-16
NL7204789A (xx) 1972-10-12
ZA722396B (en) 1972-12-27
IL39167A0 (en) 1972-06-28
ES401603A1 (es) 1975-02-16

Similar Documents

Publication Publication Date Title
CA1117013A (en) Method for treating kidney stones
US4690823A (en) Ibuprofen-containing soft gelatin capsules and process for preparing same
JP3678745B2 (ja) 高濃度アセトアミノフェン溶液含有ゼラチンカプセル
DE60126433T2 (de) Prozess zur herstellung von pharmazeutischen zusammensetzungen zur verwendung mit weichgelatine formulierungen
JPS63145239A (ja) Ｎｍｒ診断剤およびその製法
NZ213185A (en) Pharmaceutical suspensions containing sucralfate
HRP920192A2 (hr) Farmaceutski pripravak prikladan za djelovanje na retikuloendotelni sistem, te za tretiranje mucoviscidoza i sindroma kronične boli koji potječu od degenerativnih lokomotornih bolesti ili prate bolesti tumornog podrijetla, postupak njegovog dobivanja i upotreba
KR20150028239A (ko) 펙틴 수용액
US4927638A (en) Etoposide solutions
TWI240630B (en) Buffered compositions for dialysis
IE42950B1 (en) Improvements in or relating to oral x-ray contrast preparations
JPH0347161A (ja) ５―アミノサリチル酸の安定な液体形
IE74244B1 (en) A process for preparing an antibiotic composition
US3794722A (en) Iron composition for treating anemia
EP4027977A1 (en) Pharmaceutical composition of bimatoprost and timolol
JP2563336B2 (ja) 角膜透過促進点眼剤
JPH0687762A (ja) 保存安定性硫酸グルコースアミン経口薬剤とその製造方法
CN101461801B (zh) 一种奥沙利铂药物组合物及其制备方法
IL39167A (en) X-ray shading agents containing a water soluble salt of 3-acetamido-5-hydroxy-acetamido-2,4,6-triiodobenzoic acid
CN109091500A (zh) 一种小儿复方电解质葡萄糖注射液及其制备方法
US2823163A (en) Antivaginitis process and cation exchange resin composition
DE60120630T2 (de) Pharmazeutische Zusammensetzung enthaltend Xanthangummi
CN110200905A (zh) 一种盐酸氨溴索组合物及其注射液与应用
US3325370A (en) Aqueous x-ray contrast composition containing a sodium salt of an iodinated organic acid and magnesium ions
CN101780084A (zh) 一种以左旋亚叶酸或其盐为主要成分的注射用组合物